In vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana

被引:27
作者
Bola, Christiana [1 ]
Adeniyi, A. [1 ]
Lawal, Temitope Olufunmilayo [2 ]
Mahady, Gail B.
机构
[1] Univ Ibadan, Dept Pharmaceut Microbiol, Ibadan, Nigeria
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
关键词
Eucalyptus camaldalensis; Eucalyptus torelliana; Helicobacter pylori; anti-H. pylori activity;
D O I
10.1080/13880200802448708
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The in vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis Dehnh. and Eucalyptus torelliana F.Muell. (Myrtaceae), Nigerian medicinal plants, was investigated in six strains of H. pylori, namely, ATCC 4504, ATCC 47619, A2, T18984, 019A, and A6. The susceptibility of these strains was determined using a standardized agar dilution method (National Committee for Clinical Laboratory Standards guidelines) with Mueller-Hinton agar, supplemented with defibrinated horse blood. The minimum inhibitory concentrations of the crude extracts against all the tested strains ranged from 12.5 to 400 mu g/mL. Phytochemical screening of the plant extracts revealed the presence of tannins, saponins, and cardenolides. The anti-H. pylon activities demonstrated by these plants may be attributed to their chemical constituents, and explain their reported traditional uses, as well as their gastroprotective properties as demonstrated previously in experimental animals. The results of this work suggest that, in accordance with their traditional medical use in Nigeria, E. camaldalensis and E. torelliana have some therapeutic potential against H. pylori, and thus are of interest for the treatment of H. pylori infections.
引用
收藏
页码:99 / 102
页数:4
相关论文
共 17 条
[1]  
Adeniyi B A, 1996, Afr J Med Med Sci, V25, P221
[2]  
Adeniyi B. A., 2006, IJP - International Journal of Pharmacology, V2, P362
[3]   Antibiotic resistance problems with Helicobacter pylori [J].
Alarcón, T ;
Domingo, D ;
López-Brea, M .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 (01) :19-26
[4]  
[Anonymous], ETHNOMEDICAL USES PL
[5]  
BRUNETON J, 1999, PHARMACOGNOSY PHYTOC, P555
[6]  
DAVID S, 1996, PHARM J, V257, P720
[7]   Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women [J].
Fujimori, S ;
Kishida, T ;
Kobayashi, T ;
Sekita, Y ;
Seo, T ;
Nagata, K ;
Tatsuguchi, A ;
Gudis, K ;
Yokoi, K ;
Tanaka, N ;
Yamashita, K ;
Tajiri, T ;
Ohaki, Y ;
Sakamoto, C .
JOURNAL OF GASTROENTEROLOGY, 2005, 40 (09) :887-893
[8]  
GLASBY JS, 1999, DICT PLANTS CONTAINI, P125
[9]  
HARBORNE JB, 1991, PHYTOCHEMICAL METHOD, P228
[10]  
KUIPERS EJ, 1995, ALIMENT PHARM THERAP, V9, P59